Mosquito Borne Disease Market

Mosquito Borne Disease Market Driven by Rising Prevalence of Diseases Like Dengue and Zika

by

Mosquito borne diseases are transmitted through the bite of an infected female mosquito. Some of the major mosquito borne diseases include malaria, dengue, chikungunya, zika, yellow fever and west nile virus. There has been a rising prevalence of diseases like dengue and zika globally due to changing climatic conditions and rising mosquito population which is driving the growth of the mosquito borne disease market.

The Mosquito Borne Disease Market is estimated to be valued at US$ 3.59 Billion in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024 To 2031.

The Mosquito Borne Disease Market Size comprises of products like diagnostic instruments and kits which help in the diagnosis of diseases like malaria, dengue, chikungunya, zika etc. Diagnostic instruments including mosquito population monitoring devices, thermal foggers, larval source management gadgets and tools help in reducing mosquito population and spread of diseases. Early diagnosis is important for effective disease management and treatment which is increasing the demand for diagnostic kits. The market is estimated to grow significantly owing to the ongoing research and development for advanced diagnostic solutions and vaccines.

Key Takeaways

Key players operating in the Mosquito Borne Disease Market are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed.

The major opportunities in the market include development of affordable diagnostic kits and monitoring devices for resource constrained regions. Growing awareness about mosquito borne diseases and importance of early diagnosis is another key opportunity.

The market is witnessing significant growth in regions like Asia Pacific and Latin America due to rising incidents of dengue, chikungunya and zika virus. Major players are focusing on expanding their presence in high potential emerging markets through collaborations and partnerships.

Market Drivers

The major driver for the growth of Mosquito Borne Disease Market is the rising prevalence of vector borne diseases globally due to changing environmental and climatic conditions leading to increasing mosquito population. According to the WHO, there has been massive increase in mosquito borne diseases like dengue, malaria and zika virus across tropical and subtropical regions in recent years which is propelling the demand for diagnostic testing and monitoring. Other key drivers include increased healthcare expenditure on vector control programs and improvement in disease diagnosis and treatment. Growing awareness about mosquito borne diseases and importance of early diagnosis is another significant factor augmenting the market growth.

PEST Analysis

Political: The growing concern of government bodies towards vector-borne diseases and initiatives taken by WHO for mosquito-borne disease treatment and prevention could influence the market growth. However, differing regulations across countries make the market unpredictable.

Economic: Higher disposable incomes and rising healthcare expenditures in developing nations is supporting the market expansion. But economic slowdowns can negatively impact the demand.

Social: Increasing awareness about vector-borne diseases and their treatment options is driving the adoption of related medical products and services. However, social stigmas associated still remain a challenge.

Technological: Advancements in diagnostic technologies help early detection and monitoring of mosquito-borne diseases. Further, new product launches incorporating novel techniques are expanding treatment approaches. However, developing new technologies require huge investments.

Geographical regions where market in terms of value is concentrated:

The markets in Asia Pacific and North America hold major shares of the global mosquito-borne disease treatment market in terms of value, attributed to high disease prevalence, rising healthcare investments, and presence of leading industry players in these regions. Countries like United States, China, and India have been reporting a large number of cases of vector-borne illnesses in recent years.

Fastest growing region for the market:

The market in Asia Pacific region is expected to witness the highest growth during the forecast period, rising at around 8%. Factors such as the increasing disposable incomes, growing health awareness, expanding private healthcare infrastructure, and conducive government support are supporting the strong market growth in Asia Pacific countries including India, Malaysia, Indonesia, and Australia.

*Note:
1.  Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it